Comparing two different techniques of rectus sheath blocks in enhancing the analgesic efficacy in cancer patients undergoing abdominal surgeries

Comparison of spread of local anaesthetic mixture and their analgesic efficacy between two point and four point rectus sheath block in cancer patients undergoing midline laparotomy surgeries - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083443

Enrollment

Registered

2025-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C15-C26- Malignant neoplasms of digestive organs

Interventions

Intervention1: 2 point rectus sheath block: 0.25% ropivacaine- 30ml each site given at 2 sites(total 150mg) as a single shot injection in the muscular plane under ultrasound guidance Control Intervent

Eligibility

Inclusion criteria

Inclusion criteria: patient willing to give informed consent, assessed under ASA 1-4, weight more than 50kg

Exclusion criteria

Exclusion criteria: patient with low IQ, allergic to LA, infection at the site of injection

Design outcomes

Primary

Measure	Time frame
to evaluate and compare the spread of LA in rectus sheath plane between two techniquesTimepoint: 10minutes after the block	—

Secondary

Measure	Time frame
To evaluate & compare the efficacy of analgesia intraoperatively based on vitals & requirement of epidural & intravenous analgesics & postoperatively based on VAS score between two techniques Timepoint: intraoperatively every 10min until first 1hr & 30min thereafter & during postop period at 0, 2, 4, 6, 8 & 12hrs	—

Countries

India

Contacts

Public ContactDr.Sivabalakumaran

MVR Cancer Center and Research Institute

k.sivabalakumaran@gmail.com9600994850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026